These new proposals adhere closely to the 2009 EU regulations as a model for the marketing of cosmetics, and contain strict new guidelines on nano-materials which require consumers and the marketplace to be made aware of their presence in products.
The bill also lowers barriers to trade by removing a supplier’s need to seek a registration certificate. They alter the responsibilities of the Ministry of Health to focus more strongly on formulating rules and regulations for cosmetics marketing in Israel.
New regulations ensure that products introduced on the market must comply with good manufacturing practice (GMP), and also holds distributers to high standards regarding storage and transportation.
The Israeli Department of Health has stated that the new regulations will allow for better protection of consumers whilst also lowering barriers to entry for trade.
In a description of the proposed law, the notifying body commented: “This draft regulation fully adopts the European model for marketing of cosmetics outlined in ‘Reuglation (EC) No. 1223/2009’…which according to professionals provides the best basis for controlling the marketing of cosmetics, the lowering of trade barriers and the safeguarding of consumers.”
New nanomaterial rules
One important new regulation requires products containing nano-materials to be clearly labeled, and for the market to be notified six months before they are introduced.
Other new requirements introduced in these regulations include a different process for importing and introducing products into Israel, which denies manufacturers the right to introduce items without first obtaining a certificate of free sale from another recognized country.
It also ensures that every individual cosmetics/personal care item is linked to a legally responsible individual, who can be held accountable for the product and any regulatory issues related to it.
The document establishes a National Cosmetics Poison Center, which will be a centralized repository of information on ingredients, including dosages, and will be for emergency use in the case of consumers who need medical treatment after being affected by beauty products.